disease biomarkers

What Are the Challenges and Considerations?

Despite the potential, there are challenges:
Biocompatibility: Ensuring that nanoparticles do not elicit adverse immune responses.
Stability: Maintaining the stability of nanoparticles in biological environments.
Scalability: Producing nanoparticles consistently and cost-effectively for widespread use.
Regulatory approvals: Navigating the regulatory landscape for clinical applications.

Frequently asked queries:

Partnered Content Networks

Relevant Topics